Tong JH - Search Results

1

Expanding the use of arsenic trioxide: leukemias and beyond.

Chen Z, Chen GQ, Shen ZX, Sun GL, Tong JH, Wang ZY, Chen SJ. Chen Z, et al. Among authors: tong jh. Semin Hematol. 2002 Apr;39(2 Suppl 1):22-6. doi: 10.1053/shem.2002.33611. Semin Hematol. 2002. PMID: 12012319 Review.

2

Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk.

Zhu Q, Zhang JW, Zhu HQ, Shen YL, Flexor M, Jia PM, Yu Y, Cai X, Waxman S, Lanotte M, Chen SJ, Chen Z, Tong JH. Zhu Q, et al. Among authors: tong jh. Blood. 2002 Feb 1;99(3):1014-22. Blood. 2002. PMID: 11807007 Free article.

3

[Experimental study of low dose arsenic trioxide in treatment of patients with acute promyelocytic leukemia].

Jia PM, Zhu Q, Yu Y, Chen GQ, Chen SJ, Chen Z, Wang ZY, Tong JH. Jia PM, et al. Among authors: tong jh. Ai Zheng. 2002 Apr;21(4):337-40. Ai Zheng. 2002. PMID: 12452006 Chinese.

4

Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy.

Fang J, Chen SJ, Tong JH, Wang ZG, Chen GQ, Chen Z. Fang J, et al. Among authors: tong jh. Cancer Biol Ther. 2002 Nov-Dec;1(6):614-20. doi: 10.4161/cbt.308. Cancer Biol Ther. 2002. PMID: 12642682 Review.

5

[In vitro study of the effects of arsenic trioxide combined with 8-CPT-cAMP on differentiation induction in retinoic acid resistant acute promyelocytic leukemia cells].

Zhu Q, Yu Y, Jia PM, Cai X, Chen SJ, Chen Z, Wang ZY, Tong JH. Zhu Q, et al. Among authors: tong jh. Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):6-9. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12679001 Chinese.

6

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de Thé H, Chen SJ, Chen Z. Zhang XW, et al. Among authors: tong jh. Science. 2010 Apr 9;328(5975):240-3. doi: 10.1126/science.1183424. Science. 2010. PMID: 20378816

7

IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1.

Lou YJ, Pan XR, Jia PM, Li D, Xiao S, Zhang ZL, Chen SJ, Chen Z, Tong JH. Lou YJ, et al. Among authors: tong jh. Cancer Res. 2009 Apr 15;69(8):3673-80. doi: 10.1158/0008-5472.CAN-08-4922. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351818

8

[Molecular study of the mechanism of chromosomal translocation (15;17) in acute promyelocytic leukemia (APL)].

Dong S, Tong J, Wu Y, Cai J, Sun G, Chen S, Wang Z, Chen S, Chen Z, Geng J, et al. Dong S, et al. Yi Chuan Xue Bao. 1993;20(5):381-8. Yi Chuan Xue Bao. 1993. PMID: 8161469 Chinese.

9

Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variants.

Tong JH, Dong S, Geng JP, Huang W, Wang ZY, Sun GL, Chen SJ, Chen Z, Larsen CJ, Berger R. Tong JH, et al. Oncogene. 1992 Feb;7(2):311-6. Oncogene. 1992. PMID: 1312695

10

Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.

Chen SJ, Chen Z, Chen A, Tong JH, Dong S, Wang ZY, Waxman S, Zelent A. Chen SJ, et al. Among authors: tong jh. Oncogene. 1992 Jun;7(6):1223-32. Oncogene. 1992. PMID: 1375719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page